ECO ANIMAL HEALTH GROUP PLC

AGM Information • Mar 4, 2021

National Storage Mechanism | Additional information

RNS Number : 2362R

Eco Animal Health Group PLC

04 March 2021

4 March 2021

ECO Animal Health Group plc ("the Company")

(AIM: EAH)

Result of Annual General Meeting and General Meeting

ECO Animal Health Group plc announces that at both its Annual General Meeting and General Meeting held earlier today ("AGM" and "GM" respectively), all resolutions proposed to the meetings were duly passed on a poll.

At the AGM the total votes cast on each resolution were as follows:

Resolution	For	%	Against	%	Withheld
1	39,817,344	97.68	946,305	2.32	1,452
2	40,763,180	99.99	469	0.01	1,452
3	40,751,532	99.97	12,117	0.03	1,452
4	40,761,973	99.99	1,676	0.01	1,452
5	40,760,507	99.99	4,141	0.01	453
6	40,316,884	98.90	447,764	1.10	453
7	40,759,099	99.99	5,549	0.01	453

At the GM the total votes cast on each resolution were as follows:

Resolution	For	%	Against	%	Withheld
1	39,491,382	96.74	886,334	2.17	445,053
2	36,701,055	89.90	3,676,661	9.01	445,053

Contacts:

ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO)	020 8447 8899
IFC Advisory Graham Herring Zach Cohen	020 3934 6630
N+1 Singer (Nominated Adviser & Joint Broker) Mark Taylor Iqra Amin	020 7496 3000
Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden	020 7418 8900

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new product

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMEASDLEESFEFA